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Human peripheral blood monocytes, that are un-
stimulated in vitro, permit free multiplication of
intracellular Mycobacterium tuberculosis after 72 h in
culture. There was no killing of bacilli in the intra-
cellular environment even after in vitro activation of
monocytes with a cocktail of lipopolysaccharide,
phorbol myristate acetate, interferon gamma and
tumour necrosis factor-alpha. We also tested the
ability of adenosine triphosphate (ATP) in reducing
the intracellular viability of mycobacteria. Infected
monocytes upon ATP treatment underwent cell death,
but no loss in the intracellular viability of M. tuber-
culosis or M. smegmatis could be observed.
TUBERCULOSIS remains an important global health problem
with approximately one billion people presently infected
with the disease1. During hundred years since the dis-
covery of the tubercle bacillus, the increased under-
standing of bacteriological and pathological characters
has resulted in important public health measures such
as pasteurization of milk and BCG vaccination. However,
it was chemotherapy that was introduced during the end
of the last century which brought about tremendous
decline in the mortality rates2. But the increasing number
of multidrug resistant M. tuberculosis isolates from both
AIDS and non-AIDS patients is an ominous trend that
threatens the tuberculosis eradication programme3.
Tuberculosis is actually on the rise again. The recru-
descence of tuberculosis appears to have its roots in
the AIDS epidemic, although declining control pro-
grammes, increased levels of homelessness and drug
addiction are also contributing factors2.
*For correspondence. (e-mail: trcicmr@giasmd01.vsnl.net.in; tbrc@
giasmd01.vsnl.net.in)
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The major phagocytic cell involved in protection
against M. tuberculosis infection is probably the activated
macrophages. Activation of macrophages is brought about
by the cytokines released by the antigen sensitized
specific T lymphocytes. The mechanisms mediating
growth inhibition of mycobacteria by activated macro-
phages has not been elucidated till date.
In order to study the host parasite relationship in
tuberculosis, we infected the human peripheral blood
monocytes in vitro with M. tuberculosis and the fate
of M. tuberculosis inside the unstimulated and cytokine
stimulated human monocytes was studied. We also
attempted to study the intracellular fate of M. tuberculosis
and M. smegmatis, following treatment of monocytes
with adenosine triphosphate (ATP).
Interferon gamma (IFN- g) and tumour necrosis
factor-alpha (TNF- a) were purchased from Genzyme
(Cambridge, MA). ATP, lipopolysaccharide (LPS),
phorbol myristate acetate (PMA) and RPMI 1640 were
purchased from Sigma (St. Louis, MO). OADC was
purchased from Difco (Detroit, MI) and lymphocyte
separation medium was purchased from Flow Labo-
ratories (Scotland, UK).
Blood (30-35 ml) was collected from healthy volun-
teers in a heparinized container (IO U/ml). The mono-
nuclear cells were separated by centrifugation at
400 x g for 30 min on Ficoll hypaque. These cells were
washed three times with Hanks balanced salt solution
(HBSS) at 300 x g for 10 min. After the final wash the
cells were suspended in Roswell Park Memorial Institute
(RPMI 1640) medium containing pooled heat inactivated
normal human serum (PHINHS). Total number of viable
mononuclear cells in the suspension was ascertained by
trypan blue dye exclusion. One million mononuclear
cells were added per well in a 96 well flat bottomed
plate and incubated for 4.5 min at 37°C, 5% CO2 in a
humidified atmosphere for adherence. The non-adherent
cells were removed by gentle washing. The adherent
monocytes were cultured in RPMI 1640 containing 5%
PHINHS. Monocytes were maintained in culture for 24 h
prior to infection with M. tuberculosis.
M. tuberculosis (H37Rv) was grown in Dubos broth
containing 1% Tween 80. Single cell suspension of
M. tuberculosis, at peak log phase of growth was used
for infection. At the time of infection, the bacterial cell
suspension was washed three times in HBSS to remove
Tween 80. The bacterial cell suspension was subjected
to mild sonication using Fisher sonic dismembrator
(Model 300) for 30 s twice to disaggregate the clumps.
Total number of M. tuberculosis in the suspension was
ascertained by counts in a Thoma counting chamber.
There was no loss in viability which was checked by
trypan blue exclusion method.
For every single monocyte, approximately ten bacilli
were added and incubated at 37°C for 1 h, after which
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the extracellular organisms were removed by gentle
washing. Infected monocytes were maintained in RPMI
containing 5% PHINHS. Cell free supernatant from M.
tuberculosis infected monocyte culture was plated on
7H11 agar, at all the time points to ascertain the ex-
tracellular M. tuberculosis growth.
Along with every experiment a cell-free control was
included, where M. tuberculosis was maintained in 200 µl
of RPMI containing 5% PHINHS, in order to ascertain
the growth pattern of M. tuberculosis in RPMI (Figure 1).
Freshly drawn human peripheral blood monocytes were
infected with M. tuberculosis (Monocyte: M. tuberculosis
ratio is 1 : 10). 1 h later, the extracellular organisms
were removed. Infected monocytes were cultured in
culture medium containing LPS (from E. coli serotype
No. 0127 B8) at three different concentrations 5 ng/ml,
5 pg/ml and 5 fg/ml.
Freshly drawn human monocytes were cultured in
RPMI containing TNF- a and IFN- g at two concentrations
100 U/ml and 1000 U/ml each. 24 h later, the cytokine
treated monocytes were infected with M. tuberculosis
(Monocyte: M. tuberculosis ratio is 1 : 10). 1 h later the
extracellular organisms were removed. Infected mono-
cytes were then cultured in medium containing IFN- g
and TNF- a (at 1000 U/ml or 100 U/ml concentrations).
Along with these two cytokines LPS at a concentration
of 5 ng/ml or PMA at a concentration of 10 ng/ml or
LPS and PMA together were also added to the infected
monocytes, in separate experiments.
Infected monocytes (either untreated or cytokine
treated) were terminated at various time points, viz. I h,
24 h, 48 h, 72 h and one week after infection. During
the termination process, the infected monocytes were
lysed with sterile distilled water. The total volume of
the lysate was adjusted to 500 µl. The stock was diluted
10 and 100 times. The diluted lysate was plated on
7H11 containing oleic acid albumin dextrose complex
Figure 1. Cell free control: M. tuberculosis was cultured in 200 µl
of RPMI containing 5% PHINHS. The cultures were terminated at the
following time points, 1 h, 24 h, 48 h, 72 h and 1 week in order to
study the growth pattern of M. tuberculosis in RPMI.
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(OADC). Inoculated plates were incubated for 15 days
at 37°C to observe M. tuberculosis growth.
M. tuberculosis H37Rv strain and M. smegmatis were
processed for infection as described previously. Freshly
drawn human peripheral blood monocytes were infected
in vitro with M. tuberculosis at 1 : 10 and 1 : 1 ratio.
Unphagocytosed bacilli were removed by gentle washing,
when the macrophage : mycobacteria ratio was adjusted
to 1 : 10. Monocyte : mycobacteria ratio was adjusted to
10 : 1, when M. smegmatis was used for infection and
extracellular bacilli were removed after phagocytosis.
M. tuberculosis infected monocytes were maintained in
culture for seven days. Seven days after infection, mono-
cytes were treated with 1 mM, ATP and 6 h later, the
cultures were terminated. M. smegmatis infected human
monocytes were maintained in culture for 3 days after
infection and then treated with 1 mM ATP. M. smegmatis
infected cultures were terminated after three days, because
M. smegmatis has a short generation time as compared
to M. tuberculosis. Cultures were terminated six hours
after ATP treatment.
The termination procedure is very similar to what has
been described previously.
As seen in Figure 1 the generation time of M.
tuberculosis in RPMI containing PHINHS (cell free
control) is between 20-24 h. Human peripheral blood
monocytes infected with M. tuberculosis in vitro, inhibit
the growth and multiplication of M. tuberculosis till
72 h, after which it was able to multiply within the
intracellular environment (Figure 2). On day 8 there
was almost one log difference in colony forming units
(CFU) values as compared to day 0. Activation of
human monocytes with LPS at concentrations such as
5 ng/ml, 5 pg/ml and 5 fg/ml, did not enhance the
antimycobacterial nature of human monocytes in vitro.
Activation of human monocytes with LPS at 5 ng/ml,
Figure 2. Fate of M. tuberculosis inside human monocytes in vitro:
Human monocytes (0.1 x 106 cells/well) were infected with M. tuber-
culosis. For every single monocyte, ten bacilli were added and incubated
at 37°C for 1 h. Extracellular organisms were removed by gentle
washing. The infected cultures were terminated at the following time
points, 1, 24, 48, 72 h and 1 week after infection.
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along with IFN- g (1000 U/ml or 100 U/ml) and TNF-
a (1000 U/ml or 100 U/ml) did not alter the fate of M.
tuberculosis inside human monocytes (Figure 3). Human
monocytes treated with PMA (10 ng/ml) along with
IFN- g (1000 U/ml or 100 U/ml) and TNF- a (1000 U/ml
or 100 U/ml) handled M. tuberculosis in a similar way
as untreated monocytes (Figure 4). No changes were
observed with respect to the fate of intracellular M.
tuberculosis when human monocytes were treated with
the combination of PMA (10 ng/ml), LPS (5 ng/ml)
IFN- g (1000 U/ml and 100 U/ml) and TNF- a (1000 U/ml
and 100 U/ml) (Figure 5). The biological activity of the
Figure 3. Fate of M. tuberculosis inside TNF- a, IFN- g and LPS
treated human monocytes in vitro: Human monocytes (0.1 x 106
cells/well) were treated with TNF- a and IFN- g at two different con-
centrations (1000 U/ml of INF, 1000 U/ml of TNF- a, 5 ng of LPS and
100 U/ml of INF, 100 U/ml of TNF- a, 5 ng of LPS). 24 h later, the
cultures were infected with M. tuberculosis. Extracellular organisms
were removed by gentle washing.
Figure 4. Fate of M. tuberculosis inside TNF- a, IFN- g and PMA
treated monocytes: Human monocytes (0.1 x 106 cells/well) were treated
with TNF- a and IFN- g at two different concentrations, 1000 U/ml and
100 U/ml. 24 h later, the cultures were infected with M. tuberculosis.
The infected cultures were terminated at the following time points, 1,
24, 48, 72 h and 1 week after infection.
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cytokines that were used in the intracellular killing
experiments was confirmed by their ability to induce
H2O2 production in monocytes (Figure 6). Hydrogen
peroxide was assayed by Pick’s method4. M. tuberculosis
and M. smegmatis infected human peripheral blood mono-
cytes upon ATP treatment underwent apoptosis, but we
could observe no loss in the intracellular viability of
either M. tuberculosis or M. smegmatis (Figures 7 and 8).
Attempt was made to study the fate of M. tuberculosis
inside the human peripheral blood monocytes in vitro.
Human monocytes inhibited the growth and multiplication
of M. tuberculosis till 72 h, after which M. tuberculosis
multiplied inside the intracellular environment.
Figure 5. Fate of M. tuberculosis inside TNF- a, IFN- g, LPS and
PMA treated human monocytes: Human monocytes (0.1 x 106 cells/well)
were treated with TNF- a, IFN- g at two different concentrations,
1000 U/ml and 100 U/ml along with LPS at 5 ng/ml and PMA 10 ng/ml.
Figure 6. H202 assay: Human monocytes 0.1 x 10
6/well were treated
with IFN- g or TNF- a at 1000 U/ml concentration at the start of the
culture. The activity of the cytokines was tested at 24 h and 48 h on
human monocytes by their ability to trigger H2O2 production. at the
time of culture.
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Based on the information available in the literature,
we expect monocytes to be activated by LPS, PMA and
cytokines like TNF- a and IFN- g (refs 5-11). Intracellular
M. tuberculosis is known to induce monocytes to syn-
thesize and release TNF- a: (refs 12, 13). Moreover, when
LPS-treated monocytes are infected with M. tuberculosis,
TNF- a synthesis is very much enhanced12-14. TNF- a
plays a vital role inducing nitric oxide. Nitric oxide
metabolites play a major role in bringing about the
intracellular killing of many pathogens including
mycobacteria12. Keeping these information in mind, we
made an attempt to study the fate of M. tuberculosis
inside the LPS-treated monocytes. No difference could
be observed between LPS-treated monocytes and un-
treated monocytes with respect to handling intracellular
M. tuberculosis. Human monocytes were treated with
cytokines (TNF- a, IFN- g) to find out if the cytokines
can enhance the antimycobacterial nature of monocytes.
A great wealth of information is available on the role
of IFN- g as macrophage activating agent6,9,15-17. IFN- g
is known to activate mouse macrophages to bring about
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the intracellular killing of leishmania, trypanasoma and
M. bovis 11,12,15. Both human monocytes and mouse macro-
phages when treated with IFN- g completely eliminate
Toxoplasma gondii 9. Similarly TNF- a, is also known to
enhance the antimycobacterial nature of macrophages17,18.
In our experiments, human monocytes upon treatment
with TNF- a, IFN- g, LPS and PMA together handled M.
tuberculosis in a similar way as untreated monocytes.
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vitro 10,17,19. But there are also controversial reports about
the elevated levels of calcitriol in serum samples from
tuberculosis patients20. Therefore we were hesitant to
perform an experiment with calcitriol as one of the
macrophage activating agents. Further, recently Davies
et al. 21 have shown that a combination of TNF- a, IFN- g
and calcitriol at optimum concentration failed to enhance
the antimycobacterial nature of the human monocytes.
It is generally assumed that elimination of M. tuberculosis
from tissues of protected individuals depends on
destruction of the organisms by macrophages that are
activated by lymphokines derived from T lymphocytes.
The right combination of cytokines that activates macro-
phages and the right in vitro condition to demonstrate
the antimycobacterial nature of human monocyte has
been a matter of debate for a long time.
11.
12.
13.
14.
15.
Cohn, Z. A., J. Exp. Med., 1979, 150, 950-964.
Walker, L. and Lowrie, D. B., Nature, 1981, 293, 5827.
Murray, H. W., Spitalny, G. C. and Nathan, C. F., J. Immunol.,
1985, 134, 1982-1988.
Crowle, A. J., Ross, E. J. and Mary, M. H., Infect Immun., 1987,
55, 2945-2950.
Flesch, I. E. A. and Kaufmann, S. H. E., Infect Immun., 1990,
58, 2675-2617.
Hibbs, J. B., Res. Immmunol., 1991, 142, 565-569.
Kilborn, R. G., Res Immunol., 1991, 142, 587-588.
Mulsch., R., Res. Immunol., 1991, 142, 561-565.
Douvas, G. S., Looker, D., Vatter, A. E. and Crowle, A. J., Infect.
Immun., 1985, 50, 1-8.
16.
17.
18.
19.
20.
21.
22.
Rook, G. A. W., Steele, J., Ainsworth, M. and Champion, B. R.,
J. Immunol., 1986, 59, 333-338.
Dennis, M., Clin. Exp. Immunol., 1991, 84, 200-206.
Rigby, W. F. C., Immunol. Today, 1988, 9, 54-58.
Rook, G. A. W., Tavrene, J., Leveton, C. and Steele, J., J.
Immunol., 1987, 62, 229-234.
Cadranel, J. L., Garabedian, M., Milliron, M., Grillozo, H., Valiyrc,
D., Parllard, F., Akoun, G. and Hance, A. J., Eur. Respir. J.,
1994, 7, 1103-1110.
Davies, J. W., Dhillon, J., Brien, L. O. and Andrew, P. W., Clin.
Exp. Immunol., 1994, 96, 214-217.
Molloy, A., Laochomroonovorapong, P. and Kaplan, G., J. Exp.
Med., 1994, 180, 1499-1509.
In our observations, human monocytes inhibit the
growth and multiplication of M. tuberculosis in vitro
till 72 h, after which M. tuberculosis multiply inside the
intracellular environment of monocytes. TNF- a, IFN- g,
LPS and PMA stimulate the intracellular respiratory
burst in macrophages, but fail to inhibit the growth of
intracellular mycobacteria.
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Recently Molloy et al. 22 highlighted that tuberculosis
infection is controlled by granulomatous response and
this is intimately associated with accumulation, activation
and death of mononuclear leucocytes. Molloy et al.
pointed out that cell death could be due to necrosis or
apoptosis and provided further data to show that only
during apoptosis (induced by ATP), but not necrosis,
of chronically infected cells, 60-70% loss in intracellular
viability of BCG resulted. They assumed that observations
made on one Mycobacterium species are relevant to
another. On the contrary, when we treated M. tuberculosis
or M. smegmatis infected human monocytes with ATP,
we observed loss in monocyte viability confirming apop-
tosis with no reduction in bacterial viability. The reason
for this discrepancy is under investigation.
We conclude that there is no killing of M. tuberculosis
by unstimulated or cytokine stimulated and ATP-treated
human monocyte derived macrophages in vitro.
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